Skip to main content
Log in

Whole brain volume and cortical thickness abnormalities in Wilson’s disease: a clinical correlation study

  • Original Research
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

Wilson’s disease (WD) is an inherited autosomal recessive disorder of copper metabolism, and its neurological and neuropsychiatric manifestations are associated with copper accumulation in brain. A few neuroimaging studies have shown that gray matter atrophy in WD affects both subcortical structures and cortex. This study aims to quantitatively evaluate the morphometric brain abnormalities in patients with WD in terms of whole brain volume and cortical thickness and their associations with clinical severity of WD. Thirty patients clinically diagnosed as WD with neurological manifestations and 25 healthy controls (HC) were recruited. 3D T1-weighted images were segmented into 276 whole-brain regions of interest (ROIs) and 68 cortical ROIs. WD-vs-HC group comparisons were then conducted for each ROI. The associations between those morphometric measurements and the Global Assessment Scale (GAS) score for WD were analyzed. Compared with HC, significant WD-related volumetric decreases were found in the bilateral subcortical nuclei (putamen, globus pallidus, caudate nucleus, substantia nigra, red nucleus and thalamus), diffuse white matter and several gray matter regions. WD patients showed reduced cortical thickness in the left precentral gyrus and the left insula. Further, the volumes of the right globus pallidus, bilateral putamen, right external capsule and left superior longitudinal fasciculus were negatively correlated with GAS. Our results indicated that significant WD-related morphometric abnormalities were quantified in terms of whole-brain volumes and cortical thicknesses, some of which correlated significantly to the clinical severity of WD. Those morphometrics may provide a potentially effective biomarker of WD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aggarwal, A., Aggarwal, N., Nagral, A., Jankharia, G., & Bhatt, M. (2009). A novel global assessment scale for Wilson's disease (GAS for WD). Movement Disorders, 24(4), 509–518.

    Article  Google Scholar 

  • Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007). Wilson's disease. LANCET, 369(9559), 397–408.

    Article  CAS  Google Scholar 

  • Ashburner, J. (2009). Computational anatomy with the SPM software. Magnetic Resonance Imaging, 27(8), 1163–1174.

    Article  Google Scholar 

  • Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015). Wilson's disease and other neurological copper disorders. The Lancet Neurology, 14(1), 103–113.

    Article  CAS  Google Scholar 

  • Bostan, A. C., & Strick, P. L. (2018). The basal ganglia and the cerebellum: Nodes in an integrated network. Nature Reviews Neuroscience, 19(6), 338–350.

    Article  CAS  Google Scholar 

  • Caruana, F., Gerbella, M., Avanzini, P., Gozzo, F., Pelliccia, V., Mai, R., Abdollahi, R. O., Cardinale, F., Sartori, I., Lo Russo, G., & Rizzolatti, G. (2018). Motor and emotional behaviours elicited by electrical stimulation of the human cingulate cortex. Brain, 141(10), 3035–3051.

    Article  Google Scholar 

  • Chen, B., Wang, S., Sun, W., Shang, X., Liu, H., Liu, G., Gao, J., et al. (2017). Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment. European Journal of Radiology 93(16-23).

  • Członkowska, A., Litwin, T., Dusek, P., Ferenci, P., Lutsenko, S., Medici, V., Rybakowski, J. K., Weiss, K. H., & Schilsky, M. L. (2018). Wilson disease. Nature Reviews. Disease Primers, 4(1), 21.

    Article  Google Scholar 

  • Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical surface-based analysis. Neuroimage, 9(2), 179–194.

    Article  CAS  Google Scholar 

  • Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., Albert, M. S., & Killiany, R. J. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage, 31(3), 968–980.

    Article  Google Scholar 

  • Ferenci, P., Caca, K., Loudianos, G., Mieli-Vergani, G., Tanner, S., Sternlieb, I., Schilsky, M., Cox, D., & Berr, F. (2003). Diagnosis and phenotypic classification of Wilson disease. Liver International, 23(3), 139–142.

    Article  Google Scholar 

  • Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences, 97(20), 11050–11055.

    Article  CAS  Google Scholar 

  • Fischl, B., Sereno, M. I., Tootell, R. B., & Dale, A. M. (1999). High-resolution intersubject averaging and a coordinate system for the cortical surface. Human Brain Mapping, 8(4), 272–284.

    Article  CAS  Google Scholar 

  • Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Segonne, F., Salat, D. H., Busa, E., et al. (2004). Automatically parcellating the human cerebral cortex. Cerebral Cortex, 14(1), 11–22.

    Article  Google Scholar 

  • Guo, F., Xi, Y., Gao, M., Liu, L., Fei, N., Qin, W., Li, C., et al. (2018). Alterations in cortical thickness in nonmedicated premature ejaculation patients: A morphometric MRI study. Journal of Magnetic Resonance Imaging, 47(3), 656–662.

    Article  Google Scholar 

  • Hamilton, M. (1959). The assessment of anxiety states by rating. The British Journal of Medical Psychology, 32(1), 50–55.

    Article  CAS  Google Scholar 

  • Hamilton, M. (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23(56-62).

  • Hu, X., Chen, S., Huang, C., Qian, Y., & Yu, Y. (2017). Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson’s disease: A resting-state fMRI study. Metabolic Brain Disease, 32(3), 685–692.

    Article  Google Scholar 

  • Jadav, R., Saini, J., Sinha, S., Bagepally, B., Rao, S., & Taly, A. B. (2013). Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson’s disease. Metabolic Brain Disease, 28(3), 455–462.

    Article  CAS  Google Scholar 

  • Kalita, J., Naik, S., Bhoi, S. K., Misra, U. K., Ranjan, A., & Kumar, S. (2017). Pontomesencephalic atrophy and postural instability in Wilson disease. American Journal of Neuroradiology, 38(7), 1343–1347.

    Article  CAS  Google Scholar 

  • Kamagata, K., Zalesky, A., Hatano, T., Ueda, R., Di Biase, M.A., Okuzumi, A., Shimoji, K., et al. (2017). Gray matter abnormalities in idiopathic Parkinson's disease: Evaluation by diffusional kurtosis imaging and Neurite orientation dispersion and density imaging. Human Brain Mapping.

  • Li, W., Qin, W., Liu, H., Fan, L., Wang, J., Jiang, T., Yu, C. (2013). Subregions of the human superior frontal gyrus and their connections. Neuroimage 78(46-58).

  • Li, X., Feng, Z., Tang, W., Yu, X., Qian, Y., Liu, B., Li, X., et al. (2018). Sex differences in clinical characteristics and brain MRI change in patients with Wilson's disease in a Chinese population. Frontiers in Physiology 9(1429).

  • Liu, C.F., Padhy, S., Ramachandran, S., Wang, V.X., Efimov, A., Bernal, A., Shi, L., et al. (2019). Using deep Siamese neural networks for detection of brain asymmetries associated with Alzheimer's disease and mild cognitive impairment. Magnetic Resonance Imaging 64(190-199).

  • Lorincz, M.T. (2018). Wilson disease and related copper disorders. Handb Clin Neurol 147(279-292).

  • Mori, S., Wu, D., Ceritoglu, C., Li, Y., Kolasny, A., Vaillant, M. A., Faria, A. V., Oishi, K., & Miller, M. I. (2016). MRICloud: Delivering high-throughput MRI Neuroinformatics as cloud-based software as a service. Computing in Science & Engineering, 18(5), 21–35.

    Article  Google Scholar 

  • Rodriguez-Castro, K. I. (2015). Wilson’s disease: A review of what we have learned. World Journal of Hepatology, 7(29), 2859–2870.

    Article  Google Scholar 

  • Stezin, A., George, L., Jhunjhunwala, K., Lenka, A., Saini, J., Netravathi, M., Yadav, R., et al. (2016). Exploring cortical atrophy and its clinical and biochemical correlates in Wilson’s disease using voxel based morphometry. Parkinsonism & Related Disorders 30(52-57).

  • Tang, X., Oishi, K., Faria, A. V., Hillis, A. E., Albert, M. S., Mori, S., & Miller, M. I. (2013). Bayesian parameter estimation and segmentation in the multi-atlas random orbit model. PLoS One, 8(6), e65591.

    Article  CAS  Google Scholar 

  • Tang, X., Holland, D., Dale, A. M., Younes, L., & Miller, M. I. (2014). Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting. Human Brain Mapping, 35(8), 3701–3725.

    Article  Google Scholar 

  • Tombaugh, T. N., & McIntyre, N. J. (1992). The mini-mental state examination: A comprehensive review. Journal of the American Geriatrics Society, 40(9), 922–935.

    Article  CAS  Google Scholar 

  • Wang, H., Pouch, A., Takabe, M., Jackson, B., Gorman, J., Gorman, R., Yushkevich, P.A. (2013). Multi-atlas segmentation with robust label transfer and label fusion. Inf Process Med Imaging 23(548-559).

  • Zhang, Y., Zhou, W., Wang, S., Zhou, Q., Wang, H., Zhang, B., Huang, J., Hong, B., & Wang, X. (2019). The roles of subdivisions of human insula in emotion perception and auditory processing. Cerebral Cortex, 29(2), 517–528.

    Article  Google Scholar 

  • Zou, L., Song, Y., Zhou, X., Chu, J., & Tang, X. (2019). Regional morphometric abnormalities and clinical relevance in Wilson's disease. Movement Disorders, 34(4), 545–554.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Zhuoyi Peng, Xinbei Li, Yuliang Wang, and Yisu Tian for their research assistance, and all participants involved in this study.

Funding

This work was supported by the National Key R&D Program of China (2017YFC0112404), the National Natural Science Foundation of China (NSFC 81501546 and NSFC 81201074), and the Science and Technology Program of Guangdong Province (201508020121) and the Natural Science Foundation of Guangdong Province (2017A030313676).

Author information

Authors and Affiliations

Authors

Contributions

Conception and study design (SYK, CJP and TXY), data collection or acquisition (SYK, ZL, HXQ, QHS and ZJ), statistical analysis (SYK, ZL), interpretation of results (SYK, ZL, HYQ, QHS, TXY and CJP), drafting the manuscript work or revising it critically for important intellectual content (SYK, ZL, TXY and CJP) and approval of final version to be published and agreement to be accountable for the integrity and accuracy of all aspects of the work (All authors).

Corresponding authors

Correspondence to Xiaoying Tang or Jianping Chu.

Ethics declarations

Conflict of interests

None of the authors have a conflict of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendices

Appendices

Subjects

There were significant group differences in HAMD score (WD: 10.90 ± 5.71, HC: 1.88 ± 2.20) and HAM-A score (WD: 13.93 ± 7.35, HC: 1.32 ± 1.70) between WD and HC (P < 0.05). No significant differences were found in gender (P = 0.608, χ2 test), age (P = 0.900, Student’s t test), years of education (P = 0.270, Student’s t test) nor MMSE score (P = 0.133 for Student’s t test, P = 0.135 for χ2 test) between WD and HC. For the patients with WD, the mean total disease duration time was 43.87 ± 19.51 months (range: 12–84 months) and the mean GAS score was 15.64 ± 6.64 (range: 5–30). A higher GAS score indicates a more severe clinical symptom. (Table 1)

Table 3 Mean volumes (mm3) of whole brain ROIs showing significant WD-vs-HC group differences

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, Y., Zou, L., Zhao, J. et al. Whole brain volume and cortical thickness abnormalities in Wilson’s disease: a clinical correlation study. Brain Imaging and Behavior 15, 1778–1787 (2021). https://doi.org/10.1007/s11682-020-00373-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-020-00373-9

Keywords

Navigation